$BCDA insider trading
Over the last 12 months, BioCardia insiders reported 20 buys totaling $1.1M and no sales across SEC Form 4 filings.
- Bought · 12m
- $1.1M 20 events
- Sold · 12m
- — 0 events
- Events · 12m
- 20 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 800 | $1.09 | $872 | +0.2% | — |
| Aug 17, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,400 | $0.93 | $5K | +1.4% | — |
| Aug 13, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 1,900 | $0.92 | $2K | +0.5% | — |
| Jul 29, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $0.78 | $4K | +1.4% | — |
| Jul 17, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 500 | $0.83 | $415 | +0.1% | — |
| Jul 15, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 4,300 | $0.87 | $4K | +1.2% | 2 tranches |
| Jul 10, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 7,500 | $0.96 | $7K | +2.1% | 3 tranches |
| Jul 8, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,400 | $0.96 | $5K | +1.5% | — |
| Jun 23, 2026 | STERTZER SIMON HD | ▲ Buy | 109,200 | $0.95 | $104K | +191.1% | 2 tranches |
| Jun 18, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 2,300 | $0.89 | $2K | +0.8% | 2 tranches |
| Jun 9, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $0.85 | $4K | +1.7% | — |
| Apr 29, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $1.11 | $6K | +1.8% | — |
| Apr 21, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 1,000 | $1.23 | $1K | +0.4% | 2 tranches |
| Mar 25, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 900 | $1.23 | $1K | +0.3% | 2 tranches |
| Feb 4, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $1.13 | $6K | +1.9% | — |
| Jan 21, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 900 | $1.33 | $1K | +0.3% | 2 tranches |
| Dec 17, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 1,100 | $1.31 | $1K | +0.4% | 2 tranches |
| Sep 19, 2025 | STERTZER SIMON HD | ▲ Buy | 398,400 | $1.25 | $498K | +206.8% | indirect |
| Sep 19, 2025 | Blank Andrew ScottD | ▲ Buy | 288,000 | $1.25 | $360K | +83.2% | indirect |
| Sep 19, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 48,000 | $1.25 | $60K | +28.4% | — |
| Aug 22, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 700 | $1.83 | $1K | +0.4% | — |
| Aug 13, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 100 | $1.83 | $183 | +0.1% | — |
| Aug 12, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 400 | $1.75 | $700 | +0.2% | — |
| Aug 11, 2025 | Altman PeterPresident and CEO · O·D | ▲ Buy | 1,700 | $1.76 | $3K | +1% | — |
Every $BCDA filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? BioCardia filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BCDA feed.